John Milad
Healthcare Venture Capitalist - Executive - Board Member
John E. Milad is a healthcare venture capitalist with over 25 years of experience in leadership roles across the UK, USA, and Europe.
Currently serving as a Partner at Downing LLP, co-heading Healthcare Ventures and guiding HealthTech start-ups toward success.
Former CEO of Quanta Dialysis Technologies, where he played a pivotal role in transforming it into one of the UK's top emerging MedTech companies.
Notable achievements at Quanta include raising nearly $400M in funding, establishing commercial operations, launching in the UK and the USA, and winning the prestigious MacRobert Award from the Royal Academy of Engineering.
Previous roles include Investment Director at NBGI Ventures, executive positions at Nitec Pharma, and experience in investment banking at Nomura and Lehman Brothers.
Recognized in the Sunday Times Maserati List as one of the UK's 'Top 100 Game Changing Innovators and Entrepreneurs'.
Educational background includes a BA from The University of Chicago.